Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
The British Journal of Dermatology|January 21, 2023
Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapiesStephanie L Schell, Zhaoyuan Cong, Mackenzie L Sennett, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2017
Fragment-based discovery of a potent NAMPT inhibitorAlla Korepanova, Kenton L Longenecker, Steve D Pratt, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 27, 2022
Evolution of the facial skin microbiome during puberty in normal and acne skinAndrea M Schneider, Zachary T Nolan, Kalins Banerjee, et al.The British Journal of Dermatology|December 21, 2024
Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativaStephanie L Schell, Mackenzie L Sennett, Robert P Feehan, et al.Biochemical and Biophysical Research Communications|July 31, 2017
Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD<sup>+</sup> biosynthesis pathway and NAMPT mutationJun Guo, Lloyd T Lam, Kenton L Longenecker, et al.Experimental Dermatology|March 31, 2023
Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiomeZachary T Nolan, Kalins Banerjee, Zhaoyuan Cong, et al.Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitorsRavi Kurukulasuriya, Jeffrey J Rohde, Bruce G Szczepankiewicz, et al.Protein Science : a Publication of the Protein Society|December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closureKenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.Biochemistry|June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitorsKenton L Longenecker, Kent D Stewart, David J Madar, et al.Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.Pageof 7